PDRN vs PLLA: Different Approaches in Regenerative Aesthetic Injectables January 16, 2026 | by Hyacol Team Introduction Regenerative and biostimulatory injectables have become an important part of professional aesthetic treatment programs. Among them, PDRN... Read More →
Understanding Collagen Injections: Type I vs Type III January 16, 2026 | by Hyacol Team Introduction Collagen injections are widely used in medical aesthetic treatments to support skin structure and tissue quality. Among... Read More →
Bulk Supply of HA and Collagen Injectables for Global Markets December 27, 2025 | by Hyacol Team The demand for aesthetic injectables is booming worldwide, with the Asia-Pacific region emerging as the fastest-growing market .... Read More →
MOQ, Lead Time, and Quality Control in Dermal Filler Manufacturing December 27, 2025 | by Hyacol Team For brands and distributors sourcing dermal fillers, three operational factors—Minimum Order Quantity (MOQ), lead time, and Quality Control... Read More →
OEM & ODM Solutions for Aesthetic Injectable Brands December 27, 2025 | by Hyacol Team The decision between OEM (Original Equipment Manufacturing) and ODM (Original Design Manufacturing) is a pivotal strategic choice for... Read More →
Private Label Dermal Fillers: What Distributors Should Know December 27, 2025 | by Hyacol Team For distributors aiming to build a distinctive brand identity in the aesthetic market, private label dermal fillers present a... Read More →